Back to companies
Foghorn Therapeutics Inc.
FHTXUSNASDAQPharmaceuticals & HealthcareFoghorn Therapeutics Inc.
Revenue
$30.9mn
YoY +36.8%
Operating income
-$86.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API